Clinical trial of “hoa long” pill on patients with herpes

The clinical trial of Hoa Long pills was performed in 46 patients with Herpes simplex type I and II. The result showed that: The drug shortened the therapeutic duration and decreased the recrudescence in comparison with control lot. The drug recovered the state of decreased immunity, especially immunoglobulins, leukocytes, lymphocytes, CD5+ and CD72+.